LY-2300559

DB13016InvestigationalSmall molecule

Ly2300559 has been used in trials studying the prevention of Migraine Headache.

Chemical structure of LY-2300559
Formula / weight
C26H26O6 · 434.488 g/mol (avg)
Code names
LY2300559

Resolves to

Compound
UNIIZ572ZBT8XLCAS889116-06-7PubChem11611800
Structure
InChIKeyDWQVYDLTPMGYNE-DEOSSOPVSA-NSMILESCCCC1=C(OCC2=CC=C(C=C2)[C@H](O)C2=CC=CC(=C2)C(O)=O)C=CC(C(C)=O)=C1O
Targets
Q9Y271CYSLTR1Q14416GRM2

What you can answer from here — as of January 29, 2025

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
1Clinical trialPhase, status and sponsor resolved per trial
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with LY-2300559, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In